Cardiomyopathy, Sarcoidosis of the Heart
Conditions
Keywords
Implantable Cardioverter-Defibrillator (ICD)- pre-existing
Brief summary
The purpose of this study is to identify patients with cardiac sarcoidosis who may be at risk for sudden death.
Detailed description
Sarcoidosis is an inflammatory disease that can effect many organ systems. Patients with sarcoidosis involving the heart are at risk of sudden death related to ventricular arrythmias. However, we currently do not have a clinical test which can predict sudden cardiac death in these patients. While implantable cardioverter defibrillators(ICDs) can prevent sudden cardiac death in high risk patients, we do not know which patients will benefit from implantation of these devices. This clinical problem is important because we would like to identify patients at risk for sudden death who will benefit from ICD implantation. Additionally, we would like to avoid the risks to patients and financial expenses of inserting ICDs in patients who will not benefit from them.
Interventions
None listed
Sponsors
Stanford University
Icahn School of Medicine at Mount Sinai
Weill Medical College of Cornell University
The Cleveland Clinic
Virginia Commonwealth University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of Cardiac Sarcoidosis * Previous Implantable Cardioverter Defibrillator (ICD)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| retrospective collection of demographic and clinical data on patients with cardiac sarcoidosis who had an ICD implanted to correlate clinical variables with ICD therapies for ventricular arrhythmias | one year |
Countries
United States
Outcome results
None listed